$REGN insider trading

Over the last 12 months, Regeneron Pharmaceuticals insiders reported no purchases and 25 sales totaling $64.6M across SEC Form 4 filings. 72% of those filings were made under pre-arranged 10b5-1 trading plans.

—
$64.6M
25
11
72%
Side
$100K$1.0M$10M$100MAug '26SepOctNov
RYAN ARTHUR F
Guarini Kathryn
McCourt Marion
Pitofsky Jason
Zoghbi Huda Y

All insider trades

Scroll the table sideways for price, value and marks.

Nov 17, 2026SING GEORGE L▼ SaleDiscretionary2,000$958.97$1.9M-8%
Nov 17, 2026MURPHY ANDREW J▼ SaleNon-discretionary5,011$957.76$4.8M-9.7%
Nov 16, 2026McCourt Marion▼ SaleNon-discretionary566$960.25$544K-5.2%
Nov 4, 2026Pitofsky Jason▼ SaleDiscretionary179$950.76$170K-100%
Nov 4, 2026Pitofsky Jason▼ SaleDiscretionary3,883$941.79$3.7M-47.6%
Nov 3, 2026Zoghbi Huda Y▼ SaleDiscretionary7,439$970.46$7.2M-81.4%
Nov 2, 2026SING GEORGE L▼ SaleDiscretionary21,129$964.38$20.4M-45.7%
Nov 2, 2026POON CHRISTINE A▼ SaleDiscretionary7,830$969.09$7.6M-60%
Nov 2, 2026LAROSA JOSEPH J▼ SaleDiscretionary4,466$965.49$4.3M-10.3%
Oct 30, 2026Guarini Kathryn▼ SaleNon-discretionary400$900$360K-39.9%
Oct 30, 2026BROWN MICHAEL S▼ SaleNon-discretionary1,929$875$1.7M-58.3%
Oct 30, 2026McCourt Marion▼ SaleNon-discretionary1,132$869.43$984K-9.4%
Oct 14, 2026MURPHY ANDREW J▼ SaleNon-discretionary4,147$772.7$3.2M-8%
Sep 3, 2026McCourt Marion▼ SaleNon-discretionary2,346$853.56$2.0M-16.3%
Sep 2, 2026Guarini Kathryn▼ SaleNon-discretionary400$850$340K-39.9%
Aug 10, 2026Guarini Kathryn▼ SaleNon-discretionary400$800$320K-39.9%
Aug 10, 2026Zoghbi Huda Y▼ SaleNon-discretionary800$800$640K-32%
Jul 2, 2026RYAN ARTHUR F▼ SaleNon-discretionary200$650.15$130K-1.1%
May 1, 2026RYAN ARTHUR F▼ SaleNon-discretionary100$705.24$71K-0.6%
Apr 1, 2026RYAN ARTHUR F▼ SaleNon-discretionary100$777.27$78K-0.6%
Mar 2, 2026RYAN ARTHUR F▼ SaleNon-discretionary100$785.5$79K-0.6%
Feb 19, 2026Zoghbi Huda Y▼ SaleNon-discretionary1,638$781.33$1.3M-49%
Feb 9, 2026Pitofsky Jason▼ SaleNon-discretionary2,036$778.52$1.6M-32.3%
Feb 9, 2026RYAN ARTHUR F▼ SaleNon-discretionary100$778.53$78K-0.6%
Jan 7, 2026Bassler Bonnie L▼ SaleNon-discretionary1,500$800$1.2M-46.8%
Nov 20, 2025Bassler Bonnie L▼ SaleNon-discretionary760$750$570K-32.9%
Nov 7, 2025Pitofsky Jason▼ SaleDiscretionary431$651.43$281K-9.2%
Oct 29, 2025POON CHRISTINE A▼ SaleDiscretionary6,500$654.27$4.3M-73.4%

Every $REGN filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Regeneron Pharmaceuticals filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $REGN feed.